MedPath

Horizon Therapeutics USA, Inc.

🇺🇸United States
Ownership
Subsidiary
Employees
-
Market Cap
-
Website

Clinical Trials

3

Active:3
Completed:0

Trial Phases

1 Phases

Phase 1:3

Drug Approvals

11

FDA:11

Drug Approvals

DUEXIS

Approval Date
Aug 31, 2023
FDA

Krystexxa

Approval Date
Aug 30, 2023
FDA

Vimovo

Approval Date
Jul 25, 2023
FDA

TEPEZZA

Approval Date
Jul 24, 2023
FDA

BUPHENYL

Approval Date
Apr 11, 2023
FDA

PROCYSBI

Approval Date
Feb 22, 2022
FDA

Pennsaid

Approval Date
Feb 8, 2022
FDA

Ravicti

Approval Date
Sep 13, 2021
FDA

UPLIZNA

Approval Date
Jul 27, 2021
FDA

RAYOS

Approval Date
May 24, 2021
FDA
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials

Phase 1
3 (100.0%)
No trials found

News

No news found
© Copyright 2025. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy